TP53 and pancreatic adenocarcinoma: Cytoplasmic expression of SOX9 has already been observed in pancreatic adenocarcinoma affected with p53 mutation [34], in breast cancer cells [35] and in biliary tract cancers [7], suggesting that the location of SOX9 may depend on the mutational status of the cells.